LeadsRx
Attribution and journey analytics software for enterprise marketers.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- LeadsRx, Inc.
- Entity type
- COMPANY
- Founded
- 2015
- Headquarters
- United States
- Company size
- 10–49
- Market role
- AdTech Vendor
- Official website
- leadsrx.com
What LeadsRx does
LeadsRx sells measurement software to businesses that need attribution, journey analytics, and privacy-compliant first-party data workflows. It creates value by collecting and structuring inbound traffic and conversion data, mapping touchpoints across online and offline channels, and turning that data into reporting, attribution, and optimisation outputs for marketing teams and agencies. The model combines recurring software revenue with higher-touch implementation and analyst-led service revenue.
Category differentiation
LeadsRx is a marketing measurement and attribution software business, not a lead-generation agency or consumer lead marketplace. It is also not a standalone public company; it operates as part of Unbounce.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
LeadsRx, Inc. is a US-based AdTech software company owned by Unbounce. It provides multi-touch attribution, customer journey analytics, privacy-oriented first-party data handling, and managed analytics services for marketers and agencies. Its core platform measures performance across digital and offline channels including web, search, television, radio, streaming audio, and connected TV, using proprietary first-party data collection and attribution models to connect media exposure and touchpoints to revenue outcomes. The company generates revenue through enterprise SaaS licensing and related managed services. Its direct customers are enterprise marketing teams, analytics teams, privacy and IT teams, and advertising agencies, particularly in e-commerce and B2B. Operationally, LeadsRx is no longer a long-duration standalone growth story: it operates within Unbounce’s portfolio, and the company has disclosed that the product or service will no longer be available after 30 October 2026.
Business model & monetisation
LeadsRx monetises through enterprise SaaS subscriptions for its attribution, journey analytics, and privacy products, sold primarily through direct sales and negotiated contracts. It also generates service revenue from managed implementation, measurement support, reporting, and optimisation. Commercial packaging is enterprise-oriented, with pricing shaped by data volume, channel complexity, feature scope, and service requirements.
- Enterprise attribution software
- Software Subscription
- Customer journey analytics software
- Software Subscription
- Privacy Studio and clean room capabilities
- Software Subscription
- Managed implementation and analytics support
- Service Fee
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
No sufficiently sourced and dated signals are available for this view.
Explore company relationships
Questions about LeadsRx
What is LeadsRx?
LeadsRx is an attribution and customer journey analytics software platform that measures marketing performance across digital and offline channels.
Who uses LeadsRx?
Enterprise marketers, agencies, analytics teams, and privacy or IT teams use LeadsRx to measure ROI, analyse customer journeys, and manage first-party data workflows.
How does LeadsRx make money?
LeadsRx makes money through enterprise SaaS subscriptions for its measurement products and fees for managed implementation, analytics, and optimisation services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
14 publicly documented primary sources and citations linked across the market graph.
Continue your research on LeadsRx
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.